secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001214659-23-010804
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro receives Nasdaq delisting notice; hearing scheduled for Oct 12
-----------------------------------------------------------------------------

- Nasdaq notified Alzamend on Aug 1, 2023 it failed to regain compliance with $1 bid price rule.
- Company ineligible for second 180-day period due to not meeting $5M stockholders' equity initial listing requirement.
- Delisting was scheduled for Aug 10, 2023, but stay granted pending appeal to Nasdaq Hearings Panel.
- Hearing set for Oct 12, 2023; common stock continues trading under symbol ALZN during stay.
- Company has submitted required appeal by Aug 8, 2023 deadline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923010804/0001214659-23-010804-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923010804/o872318k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-23-010804

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer